- Home
- A-Z Publications
- Protein and Peptide Letters
- Fast Track Listing
Protein and Peptide Letters - Online First
Description text for Online First listing goes here...
-
-
Exploring the Regulatory Interaction of Differentially Expressed Proteins in Cleft Palate Induced by Retinoic Acid
Authors: Liyun Chen, Aiwei Ma, Lewen Jiang, Jufeng Fan, Wenshi Jiang, Mengjing Xu, Xujue Bai, Jianda Zhou, Wancong Zhang and Shijie TangAvailable online: 25 October 2024More LessObjectiveThis study aimed to identify novel proteins involved in retinoic acid (RA)-induced embryonic cleft palate development.
MethodThe palate tissues of the control and RA-treated E14.5 were dissected and subjected to iTRAQ-based proteomic analysis.
ResultsDifferential expression analysis identified 196 significantly upregulated and 149 downregulated considerably proteins in RA-induced palate tissues. Comprehensive Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analysis revealed the significant involvement of cytoplasmic translation, ribosome biogenesis, glycolysis/gluconeogenesis, and glutathione metabolism pathways in cleft palate pathogenesis triggered by RA. In particular, ribosome-related pathways were highly enriched, while glycolysis was disrupted. Protein-protein interaction analysis, facilitated by the STRING database, revealed a tightly interconnected network of differentially expressed proteins. Further analysis using the cytoHubba plugin in Cytoscape identified ten hub proteins, including Eif4a1, Gapdh, Eno1, Imp3, Rps20, Rps27a, Eef2, Hsp90ab1, Rpl19, and Rps16, indicating their potential roles in RA-induced cleft palate development, and thus positioning them as potential biomarkers for cleft palate.
ConclusionThese findings provide valuable insights into the proteomic changes associated with RA-induced cleft palate and shed light on key pathways and proteins that can contribute significantly to the pathogenesis of this congenital condition.
-
-
-
Immunoproteomics: Approach to Diagnostic and Vaccine Development
Available online: 25 October 2024More LessThe study of large protein sets (proteomics) involved in the immunological reaction is known as immunoproteomics. The methodology of immunoproteomics plays a major role in identifying possible vaccine candidates that could protect against pathogenic infection. The study of immunogenic proteins that are expressed during the outset of infection is the focus of the cross-talk between proteomics and immune protection antigens utilizing serum. Peptide presentation by MHC provides the new ‘window’ into changes that occur in the cell. Thus, there is strong, intense pressure on the pathogen that has been mutated in such an unusual manner that it can bypass the MHC peptide presentation by the MHC molecule. The pathogen's ability to evade the immune system is strongly restricted by the two unique distinct properties of MHC molecules, i.e., polygenic and polymorphic properties. MHC-I restriction epitope identification has traditionally been accomplished using genetic motif prediction. The study of immune system proteins and their interactions is the main emphasis of the specialist field of immunoproteomics within proteomics. Methodologies include mass spectrometry (MS), SRM assay, MALDI-TOF, Chromatography, ELISA, 2DG PAGE, and bioinformatics tools. Challenges are the complexity of the immune system, protein abundance and dynamics, sample variability, post-translational modifications (PTMs), and data integration. Current advancements are enhanced mass spectrometry techniques, single-cell proteomics, artificial intelligence and machine learning, advanced protein labeling techniques, integration with other omics technologies, and functional proteomics. However, the recently emerging field of immunoproteomics has more promising possibilities in the field of peptide-based vaccines and virus-like particle vaccines. The importance of immunoproteomics technologies and methodologies, as well as their use in the field of vaccinomics, are the main topics of this review. Here, we have discussed immunoproteomics in relation to a step towards the future of vaccination.
-
-
-
The Present State and Impact of AI-Driven Computational Tools for Predicting Plant Protein Structures
Authors: Stanislaus Antony Ceasar and Heba T. EbeedAvailable online: 23 October 2024More LessSeveral key functions of plants, such as photosynthesis, nutrient transport, disease resistance, and abiotic tolerance, are manifested by several classes of proteins. Prediction of 3-dimensional (3-D) structures of proteins and their working mechanisms can have a profound impact on plant proteomics research and could help improve key agricultural traits in crop plants. This review aims to present the current status of plant protein structure determination and discuss the way forward. Most experimentally proven protein structures are available only for the model plant Arabidopsis thaliana. Most of the key crop plants have only a few hundred or fewer experimentally proven 3-D structures. Fewer than 1% of the protein sequences in the majority of plants have had their 3D structures experimentally determined, and A. thaliana is the sole plant with the highest percentage of 1.4% of protein sequences with experimentally determined structures. AI-based protein structure prediction tool AlphaFold has predicted models of several thousand proteins for many crop plants. In AlphaFold predicted protein models, soybean has the highest percentage (65%) of its UniProt protein sequences with predicted models, and a few other crop plants have also a considerable percentage of its UniProt sequences with AlphaFold predicted models. AlphaFold might help predict models and bridge the gap in plant structure determination studies. Protein structure information might lead to engineering key residues to improve the agronomical performance of crop plants.
-
-
-
Neuropeptide Network of Polycystic Ovary Syndrome – A Review
Available online: 11 September 2024More LessBackgroundPolycystic Ovary Syndrome (PCOS), the ubiquitous reproductive disorder, has been documented as highly prevalent (6-9%) in India. 10% of women globally are predicted to have the disease. The highly mutable endocrinopathy, with differential clinical criteria for each diagnosis of PCOS, can mask the severity of the syndrome by influencing the incidence and occurrence of PCOS.
Area CoveredWhen there is a solid theoretical hypothesis between the neuroendocrine origin and ovarian origin of PCOS, recent evidence supports the neuroendocrine derivation of the pathology. It is considered of neuroendocrine basis – as it controls the ovarian axis and acts as a delicate target because it possesses receptors for various gonadal hormones, neurotransmitters & neuropeptides. Can these neuroendocrine alterations, variations in central brain circuits, and neuropeptide dysregulation be the tie that would link the pathophysiology of the disorder, the occurrence of all the 1˚ and 2˚ symptoms like polycystic ovaries, hyperandrogenism, obesity, insulin resistance, etc., in PCOS?
ConclusionThis review anticipates providing a comprehensive overview of how neuropeptides such as Kisspeptin, Neurokinin B, Dynorphin A, β-Endorphin, Nesfatin, Neuropeptide Y, Phoenixin, Leptin, Ghrelin, Orexin, and Neudesin influence PCOS, the understanding of which may help to establish potential drug candidates against precise targets in these central circuits.
-
-
-
Insights into the Evolutionary Dynamics: Characterization of Disintegrin and Metalloproteinase Proteins in the Venom Gland Transcriptome of the Hemiscorpius lepturus Scorpion
Authors: Abbas Rami, Benjamin Damizadeh, Mahdi Behdani and Fatemeh Kazemi-LomedashtAvailable online: 04 September 2024More LessBackgroundThe Disintegrin and Metalloproteinase (ADAM) family, also known as the metalloproteinase/disintegrin/cysteine-rich (MDC) proteins, includes both secreted and transmembrane molecules involved in critical biological processes, such as cell migration, adhesion, and signaling. This study aimed to investigate the evolutionary relationships and structural characteristics of disintegrin and metalloproteinase proteins identified in the venom gland transcriptome of the scorpion Hemiscorpius lepturus .
MethodsUsing bioinformatics tools, we analyzed the open reading frame, conserved motifs, and primary, secondary, and tertiary structures of these proteins. Five proteins, named HLDisMet1, HLDisMet2, HLDisMet3, HLDisMet4, and HLDisMet5, were identified. Their predicted 3-D structures were within normal ranges (Z-score between -4 to -9).
ResultsPhylogenetic analysis revealed that HLDisMet1 shares similarities with proteins from various spider species ( Nephila pilipes , Argiope bruennichi , Araneus ventricosus , and Trichonephila inaurata madagascar iensis), HLDisMet2 with the scorpionCentruroides sculpturatus, HLDisMet4 with the scorpionTityus serrulatus , and HLDisMet5 with several snake species ( Python bivittatus , Vipera anatolica senliki, Protobothrops mucrosquamatus , and Naja naja ).
ConclusionThese findings highlight the significant similarities between HLDisMet proteins and those found in other venomous species, suggesting a complex and diverse evolutionary pathway for venom components. The cross-species conservation observed may indicate a convergent evolutionary strategy, where different species independently develop similar venom components to adapt to similar ecological niches or prey types. This study highlights the evolutionary significance of venom diversification and its potential applications in understanding venom biology across different species.
-
-
-
Investigation of the Expression and Regulation of SCG5 in the Context of the Chromogranin-Secretogranin Family in Malignant Tumors
Authors: Weisong Zhang, Rui Wang, Zhongquan Yi, Rongqi Guo, Yangyang Li, Yanhan Xu, Xia Li and Jianxiang SongAvailable online: 04 September 2024More LessThe SCG5 gene has been demonstrated to play an essential role in the development and progression of a range of malignant neoplasms. The regulation of SCG5 expression involves multiple biological pathways. According to relevant studies, SCG5 is differentially expressed in different cancers, and its up- or down-regulation may even affect tumour growth, invasion, and migration, which caught our attention. Therefore, we summarise the regulatory roles played by the SCG5 gene in a variety of cancers and the biological regulatory mechanisms associated with its possible promotion or inhibition of tumour biological behavior, to further explore the potential of SCG5 as a new tumour marker and hopefully provide theoretical guidance for subsequent disease research and treatment.
-